Tefibazumab
Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections[1][2].
Product Specifications
CAS Number
521079-87-8
Product Name Alternative
INH-H 2002
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/tefibazumab.html
Purity
99.90
Solubility
H2O
Smiles
[Tefibazumab]
Molecular Weight
(147.04 kDa)
References & Citations
[1]pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug;50 (8) :2751-5. |[2]Reilley S, et, al. Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers. Antimicrob Agents Chemother. 2005 Mar;49 (3) :959-62.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400501-500 1x 500 µL
Progesterone Receptor (PR501), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
A08784-2-APC 100 µg/Vial
Anti-F2RL2 Antibody Picoband® APC Conjugated
Sign In for Pricing
View Details 
GTR15325730 1 Vial
Lentiviral human TAS1R2 shRNA (UAS) - Lentiviral human TAS1R2 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 